Neuropilin
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
*NRP-1 | *NRP-1 | ||
- | **[[1kex]] – hNRP-1 B1 domain – human | + | **[[1kex]], [[2qqi]] – hNRP-1 B1 domain – human<br /> |
+ | **[[4rn5]] – hNRP-1 B1 domain<br /> | ||
+ | **[[5l73]] – hNRP-1 MAM domain<br /> | ||
**[[2qqm]] - hNRP-1 A2+B1+B2 domains<br /> | **[[2qqm]] - hNRP-1 A2+B1+B2 domains<br /> | ||
**[[4deq]] - hNRP-1 B1 domain + VEGF-A heparin-binding domain<br /> | **[[4deq]] - hNRP-1 B1 domain + VEGF-A heparin-binding domain<br /> | ||
**[[2qqn]] - hNRP-1 B1 domain + VEGF-blocking antibody | **[[2qqn]] - hNRP-1 B1 domain + VEGF-blocking antibody | ||
- | + | **[[5c7g]] – hNRP-1 B1 domain + bicine<br /> | |
+ | **[[5ijr]], [[5iyy]], [[5j1x]], [[5jgi]], [[5jgq]], [[5jhk]] – hNRP-1 B1 domain + arginine derivative<br /> | ||
**[[3i97]] - hNRP-1 B1 domains + inhibitor | **[[3i97]] - hNRP-1 B1 domains + inhibitor | ||
Line 36: | Line 39: | ||
*NRP-2 | *NRP-2 | ||
- | **[[4qdq]], [[4qds]] - hNRP-2 B1+B2 domains<br /> | + | **[[4qdq]], [[4qds]], [[2qqj]] - hNRP-2 B1+B2 domains<br /> |
- | **[[ | + | **[[5dq0]] – hNRP-2 B1 domain<br /> |
**[[4qdr]] - hNRP-2 B1+B2 domain (mutant)<br /> | **[[4qdr]] - hNRP-2 B1+B2 domain (mutant)<br /> | ||
**[[2qqo]] - hNRP-2 A2+B1+B2 domains | **[[2qqo]] - hNRP-2 A2+B1+B2 domains | ||
- | **[[2qqk]], [[2qql]] - hNRP-2 A+B domains + semaphorin-blocking antibody | + | **[[2qqk]], [[2qql]] - hNRP-2 A+B domains + semaphorin-blocking antibody<br /> |
+ | **[[5dn2]] – hNRP-2 B1 domain + VEGF-A C terminal<br /> | ||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 09:39, 22 August 2017
|
3D Structures of Neuropilin
Updated on 22-August-2017
References
- ↑ Romeo PH, Lemarchandel V, Tordjman R. Neuropilin-1 in the immune system. Adv Exp Med Biol. 2002;515:49-54. PMID:12613542
- ↑ Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: structure, function and role in disease. Biochem J. 2008 Apr 15;411(2):211-26. doi: 10.1042/BJ20071639. PMID:18363553 doi:http://dx.doi.org/10.1042/BJ20071639